Silence Therapeutics Plc (SLNCF)
2.63
+0.27
(+11.44%)
USD |
OTCM |
May 07, 09:30
Silence Therapeutics Free Cash Flow : -62.89M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Adaptimmune Therapeutics Plc | -- |
| Biodexa Pharmaceuticals Plc | -8.310M |
| Oxford Biomedica Plc | -8.653M |
| NuCana Plc | -9.668M |
| Autolus Therapeutics Plc | -311.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.66M |
| Cash from Investing (Quarterly) | -53.92M |
| Cash from Financing (Quarterly) | -0.0003M |
| Free Cash Flow Per Share (Quarterly) | -0.1176 |
| Free Cash Flow to Equity (Quarterly) | -16.64M |
| Free Cash Flow to Firm (Quarterly) | -16.66M |
| Free Cash Flow Yield | -16.88% |